Sadegh Babashah

18PUBLICATIONS
12CO-AUTHORS
Molecular targetsPredictive and prognostic markersNanomedicineHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 05, 2025
Nano-curcumin enhances the sensitivity of tamoxifen-resistant breast cancer cells via the Cyclin D1-DILA1 axis and the PI3K/AKT/mTOR pathway downregulation.

Taraneh Givi, Fatemeh Mohajerani, Zahra Moazezi Tehrankhah

|Apr 11, 2025
The transcriptional regulators GATA6 and TET1 regulate the TGF-β pathway in cancer-associated fibroblasts to promote breast cancer progression.

Mohammad H Ghazimoradi, Sadegh Babashah

|Jul 11, 2023
Colorectal cancer-secreted exosomal circ_001422 plays a role in regulating KDR expression and activating mTOR signaling in endothelial cells by targeting miR-195-5p.

Iren Ghafouri, Katayoon Pakravan, Ehsan Razmara

|Jan 21, 2023
The Promising Role of Non-Coding RNAs as Biomarkers and Therapeutic Targets for Leukemia.

Mohammad H Ghazimoradi, Naeim Karimpour-Fard, Sadegh Babashah

|Dec 03, 2022
Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.

Katayoon Pakravan, Majid Mossahebi-Mohammadi, Mohammad H Ghazimoradi

|Jan 04, 2022
Strategies to overcome the side effects of chimeric antigen receptor T cell therapy.

Mohadeseh Mirzaee Godarzee, Bashdar Mahmud Hussen, Ehsan Razmara

Pageof 3

Frequent Collaborators

6 joint publications

Ehsan Razmara

2 joint publications

Masoud Garshasbi

2 joint publications

William Chi-Shing Cho

2 joint publications

Majid Sadeghizadeh